PD

Philip Daffas

PainChek Ltd | Chief Executive Officer, Managing Director
Mr Daffas is a global business leader and people manager with an international career spanning more than 25 years with leading blue-chip healthcare corporates and novel technology start-up companies. Philip has held senior global business leader positions in Europe, US and Australia. He has been instrumental in building businesses, growing market share and developing extensive high-level customer and industry relationships in each sector on a global basis. Philip's earlier experience was gained in Europe with market leaders such as IVAC infusion systems and Shiley cardiopulmonary products. He subsequently joined Boehringer Mannheim, initially in the UK managing their diagnostics business and subsequently was promoted to a Global Marketing role in the Diabetes Care business cased in Mannheim, Germany. Other roles in Australia have included General Manager with Roche Diagnostics, Managing Director at Bio-Rad Laboratories and CEO of Applied Physiology, an Australian software start-up company in the intensive care monitoring sector.

Company and Roles

Company
Title
Tenure
Since
PCK
PainChek Ltd
  • Chief Executive Officer
  • Managing Director
7yrs, 7mthSep 2016

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
PCK
PainChek Ltd
11/03/2425,310,946N/A0N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
PCK
PainChek Ltd
11/03/24
Issued
1,193,793$0.025$29,964Participation in share purchase plan
PCK
PainChek Ltd
30/11/23
Issued
2,592,593$0.027$70,000Issue of securities
PCK
PainChek Ltd
09/11/23
Issued
5,966,587$0.042$250,000Director remuneration
PCK
PainChek Ltd
13/02/23
Issued
8,445,945$0.027$228,040Issue of securities
PCK
PainChek Ltd
03/08/22
Issued
1,024,979$0.028$28,699Rights issue